Literature DB >> 495673

Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.

R P Marrs, O A Kletzky, W F Howard, D R Mishell.   

Abstract

The disappearance of human chorionic gonadotropin (hCG) and resumption of pituitary ovarian function was investigated in 13 patients following first- and second-trimester abortions. First-trimester abortion patients (with suction curettage) had a mean time of 37.5 +/- 6.4 days for the clearance of hCG to a level of 2 mlU/ml. Second trimester abortions (with prostaglandin) had a mean time of 27.4 +/- 4.8 days. Patients undergoing second-trimester hysterectomy had a mean disappearance time of 39.7 +/- 5.3 days and only 12 days if the hysterectomy was initiated with ligation of the uterine and ovarian vessels. No significant difference in clearance time was found when it was compared on the basis of the baseline hCG levels. Based on a concomitant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) peak, nine of 12 patients resumed normal pituitary function. These LH and FSH peaks were seen even though the serum hCG levels were as high as 35 mlU/ml. Based on serum progesterone levels of greater than 3 ng/ml, all these nine patients ovulated as early as 21 days after abortion. In view of these results, the clearance of hCG after pregnancy termination depends mainly upon the type of procedure used. Moreover, in view of the early time of ovulatory recovery, contraception should be instituted within the first 2 weeks following pregnancy termination.

Entities:  

Keywords:  Abortifacient Agents; Abortion, Induced; Americas; Biology; California; Comparative Studies; Developed Countries; Endocrine System; Family Planning; Fertility Control, Postconception; Follicle Stimulating Hormone; Gonadotropins; Gonadotropins, Chorionic; Gonadotropins, Pituitary; Gynecologic Surgery; Hormones; Hysterectomy; Luteinizing Hormone; North America; Northern America; Ovulation; Physiology; Prostaglandins; Reproduction; Research Methodology; Studies; Surgery; Treatment; United States; Urogenital Surgery; Vacuum Aspiration

Mesh:

Substances:

Year:  1979        PMID: 495673     DOI: 10.1016/0002-9378(79)90383-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion.

Authors:  Amy Stoddard; David L Eisenberg
Journal:  Contraception       Date:  2011-02-11       Impact factor: 3.375

2.  Triple-test screening in in vitro fertilization pregnancies.

Authors:  I Bar-Hava; M Yitzhak; H Krissi; M Shohat; J Shalev; B Czitron; Z Ben-Rafael; R Orvieto
Journal:  J Assist Reprod Genet       Date:  2001-04       Impact factor: 3.412

3.  Management of first trimester pregnancy loss can be safely moved into the office.

Authors:  Jana L Allison; Rebecca S Sherwood; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2011

4.  Contraceptive Practices, Preferences, and Barriers Among Abortion Clients in North Carolina.

Authors:  Amy G Bryant; Ilene S Speizer; Jennifer C Hodgkinson; Alison Swiatlo; Siân L Curtis; Krista Perreira
Journal:  South Med J       Date:  2018-06       Impact factor: 0.954

Review 5.  Differential diagnosis and management of placental polyp and uterine arteriovenous malformation: Case reports and review of the literature.

Authors:  Tomoko Ishihara; Haruhiko Kanasaki; Aki Oride; Tomomi Hara; Satoru Kyo
Journal:  Womens Health (Lond)       Date:  2017-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.